{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:32:12Z","timestamp":1793334732604,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jid.2025.06.1578","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:46:00Z","timestamp":1750938360000},"page":"365-373.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United States"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-8308","authenticated-orcid":false,"given":"Christopher G.","family":"Bunick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Grada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire C.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Lipiszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiem T.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-5617","authenticated-orcid":false,"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.06.1578_bib1","series-title":"Rinvoq\u00ae prescribing information","year":"2023"},{"key":"10.1016\/j.jid.2025.06.1578_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.jid.2025.06.1578_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/CCID.S245649","article-title":"A large cross-sectional survey study of the prevalence of alopecia areata in the United States","volume":"13","author":"Benigno","year":"2020","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib4","article-title":"Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: a case report","volume":"10","author":"Bourkas","year":"2022","journal-title":"Sage Open Med Case Rep"},{"key":"10.1016\/j.jid.2025.06.1578_bib5","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.jid.2022.03.013","article-title":"T helper 2 IL-4\/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17\u2012type diseases, including seronegative arthritis and enthesitis\/enthesopathy, but not to humoral autoimmune diseases","volume":"142","author":"Bridgewood","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib6","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.06.1578_bib7","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/DER.0000000000000512","article-title":"Reactivation of alopecia areata after dupilumab therapy for atopic dermatitis","volume":"32","author":"Carnicle","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.jid.2025.06.1578_bib8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1093\/bjd\/ljac140.041","article-title":"348 Development and validation of a claims-based algorithm for moderate-to-severe atopic dermatitis using U.S. real-world data","volume":"188","author":"Chomistek","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.06.1578_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/ijt.ijt_99_17","article-title":"Alopecia areata: review of epidemiology, clinical features, pathogenesis, and new treatment options","volume":"10","author":"Darwin","year":"2018","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jid.2025.06.1578_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ced.14507","article-title":"Comorbidities of alopecia areata: a population-based cohort study","volume":"46","author":"Egeberg","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib12","series-title":"Olumiant\u00ae prescribing information","year":"2022"},{"key":"10.1016\/j.jid.2025.06.1578_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdcr.2018.10.010","article-title":"Drug-induced alopecia after dupilumab therapy","volume":"5","author":"Flanagan","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.06.1578_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/1346-8138.16839","article-title":"Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database","volume":"50","author":"George","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib15","article-title":"Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient","volume":"3","author":"Giavina-Bianchi","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jid.2025.06.1578_bib16","article-title":"Retrospective analysis of the effect of comorbid atopic dermatitis on the treatment response to topical immunotherapy in pediatric alopecia areata patients","volume":"14","author":"G\u00f6k","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.jid.2025.06.1578_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ced\/llac104","article-title":"Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study","volume":"48","author":"Holmes","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/exd.12489","article-title":"The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata","volume":"23","author":"Ito","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jdcr.2021.12.011","article-title":"Review of dupilumab-associated inflammatory arthritis: an approach to clinical analysis and management","volume":"21","author":"Jay","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.06.1578_bib22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two Phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.06.1578_bib23","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jaip.2020.01.052","article-title":"Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients","volume":"8","author":"Kridin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jid.2025.06.1578_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/ijt.ijt_67_20","article-title":"Validation of case identification for alopecia areata using international classification of diseases coding","volume":"12","author":"Lavian","year":"2020","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jid.2025.06.1578_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40257-023-00805-4","article-title":"Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis","volume":"24","author":"Ly","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1405215","article-title":"Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?","volume":"15","author":"Migayron","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.06.1578_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdcr.2017.11.020","article-title":"Alopecia areata after dupilumab for atopic dermatitis","volume":"4","author":"Mitchell","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jid.2025.06.1578_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/jamadermatol.2014.3324","article-title":"Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis","volume":"151","author":"Mohan","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jamadermatol.2024.2404","article-title":"Immune-mediated and psychiatric comorbidities among patients newly diagnosed with alopecia areata","volume":"160","author":"Mostaghimi","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ced.14381","article-title":"Drug-induced alopecia areata?","volume":"46","author":"Murad","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ced\/llad390","article-title":"Dupilumab-associated inflammatory arthritis: a literature review","volume":"49","author":"Napolitano","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib32","series-title":"Cibinqo\u00ae prescribing information","year":"2023"},{"key":"10.1016\/j.jid.2025.06.1578_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2025.06.1578_bib34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/all.15561","article-title":"Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata","volume":"78","author":"Renert-Yuval","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2025.06.1578_bib35","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1007\/s12325-021-01845-0","article-title":"Alopecia areata treatment patterns, healthcare resource utilization, and comorbidities in the US population using insurance claims","volume":"38","author":"Senna","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jid.2025.06.1578_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/12034754231168839","article-title":"Alopecia areata: an updated review for 2023","volume":"27","author":"Sibbald","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.06.1578_bib37","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/exd.14389","article-title":"Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease","volume":"30","author":"Sims","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib38","series-title":"Leqselvi\u00ae prescribing information","year":"2024"},{"key":"10.1016\/j.jid.2025.06.1578_bib39","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s13555-024-01133-z","article-title":"Characteristics and management of patients with alopecia areata and selected comorbid conditions: results from a survey in five European countries","volume":"14","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2024","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.06.1578_bib40","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bjd.18883","article-title":"The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials","volume":"183","author":"Wyrwich","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.06.1578_bib41","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25022365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25022365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:35:36Z","timestamp":1768296936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25022365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0022202X25022365"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.06.1578","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.06.1578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}